Dermata receives Australian patent for Spongilla acne treatment technology

Go back to Dermata receives Australian patent for Spongilla acne treatment technology
(NASDAQ: DRMA) Delayed: 1.42 +0.04 (2.90%)
Previous Close $1.38    52 Week High
Open $1.38    52 Week Low
Day High $1.47    P/E N/A 
Day Low $1.36    EPS
Volume 230,106       

(NASDAQ: DRMAW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High
Open $0.00    52 Week Low
Day High $0.00    P/E N/A 
Day Low $0.00    EPS
Volume 560,293